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Cancer Diagnosis Clinic Finds Answers
(Continued from page 1)

If a diagnosis has already been made,
it’s simple. The patient or referring
physician says the problem is breast
cancer or leukemia or pancreatic cancer,
and the staff in the New Patient Referral
Office knows which specialist to call.
On the other hand, if the patient
doesn’t know what the problem is (“I
have this mass in my abdomen, and my
doctor says it looks like cancer”), things
are more complicated. In the past, such
a patient frequently was told to go back
to his or her primary care physician for
a biopsy. Once the type of cancer was
identified, the patient then could be
referred to the appropriate cancer
specialist.
“There were problems with that,”
said Mary Ann Weiser, M.D., Ph.D., an
associate professor in the Department of
General Internal Medicine, Ambulatory
Treatment, and Emergency Care. “Maybe
the doctor didn’t want to do the biopsy
because it was in a difficult place, or this
was a really sick patient, or it was too
risky.” Often, doctors far from a major
medical center do not have access to the
state-of-the-art equipment necessary for
performing difficult biopsies. Others feel
that their own experience has not fully
prepared them for certain procedures,
such as exploring deep in the abdomen
to take tissue from pancreatic lesions.

Patient services coordinator Tina
Bartie-Perkins schedules tests and
appointments to expedite the evaluation
of patients in the Cancer Diagnosis Clinic.

Often, doctors far
from a major medical
center do not have
access to the stateof-the-art equipment
necessary for
performing difficult
biopsies.
The birth of a clinic
Dr. Weiser discussed the problem
with Carmen Escalante, M.D., F.A.C.P.,
who then was section chief and now is
chair (ad interim) of the Department of
General Internal Medicine, Ambulatory
Treatment, and Emergency Care, and
with Rena Sellin, M.D., a professor in
the Department of Endocrine Neoplasia
and Hormonal Disorders. From those
conversations arose the realization that
there was a niche that needed to be
filled.
“And then it was just a matter of
calling the New Patient Referral Office
and asking them, ‘Do you ever have
patients like this who call and say they
think they have cancer, or do you have
physicians trying to send patients who
have a mass that really looks like it’s a
malignancy, but they
don’t have a tissue
diagnosis?’” Dr. Weiser
said. “And their answer
was, ‘All the time.’
And so I said,

‘Well, I would like to see those
patients.’”
The response was immediate.
“Patients just started coming in on
a regular basis right from the very
beginning,” Dr. Weiser said.
The Cancer Diagnosis Clinic began
as a pilot program in 2000 and continues as a permanent part of the institution. Nearly 300 patients have been
diagnosed in the clinic, with a typical
week bringing in two to five new
patients. Dr. Weiser has seen about
95% of the patients herself, but when
she is on vacation, other physicians in
the department fill in for her.
“Occasionally, I have covered for her
in that clinic and have asked, ‘When
are you coming back?’” Dr. Escalante
said. “Because it requires skills that I
don’t often use, and she [Dr. Weiser] has
learned some of the subtleties of what
tests to order for some of these very
tough cases. She gets a lot of cases
that are not your obvious breast
cancer or your obvious colon cancer.
It is these subtle ones, like the pancreatic and neuroendocrine tumors and
that sort.”
Identifying those subtle cancers
takes practice that most physicians
never get. “It is very time-consuming,
trying to be the detective, so to speak,”
Dr. Escalante said.
Dr. Weiser is glad to have the resources available to do that detective
work. “We have the capability to do
all the unusual kinds of biopsies and
procedures,” she said. “And if these
patients have other medical problems—
diabetes, high blood pressure, and
anything else—they can see a general
internist up front, and the general
internist can keep seeing the patient
and managing these other medical
problems.”
The diagnostic process
Once a patient is in the Cancer
Diagnosis Clinic, things start moving
at a rapid pace. Patients are asked to
have any recent x-ray films with them at
their first appointment. After taking the
patient’s medical history and doing
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As part of the diagnostic evaluation of a patient in the Cancer Diagnosis Clinic, Dr. Mary
Ann Weiser reviews a computed tomography scan with Dr. Eric Tamm, an assistant
professor in the Department of Diagnostic Radiology. Dr. Weiser, who directs the clinic, is
an associate professor in the Department of General Internal Medicine, Ambulatory
Treatment, and Emergency Care.
a physical examination, Dr. Weiser
and a radiologist study the films brought
by the patient and decide on a course
of action. Naturally, that course varies
tremendously, depending on the findings.
Frequently, radiographic studies
need to be repeated to better define the
problem. To prevent delays in the initial
evaluation, the patients are scheduled
for these tests before seeing Dr. Weiser.
In most cases, a biopsy is needed to
establish a firm diagnosis. Patients who
have lesions that are located deep in the
body or near critical structures are often
referred to the Section of Vascular and
Interventional Radiology in the Department of Diagnostic Radiology for imageguided biopsy procedures. Others may
require referral to the FNA (fine-needle
aspiration) Clinic for a biopsy or to the
Department of Gastrointestinal Medicine and Nutrition for biopsy using
endoscopy with ultrasound (EUS).
“We use the GI department quite a
bit for diagnosis, because the fact is that
most of the patients who are referred to
me have something in their abdomen,”
Dr. Weiser said. “I’ve also asked them
to perform biopsies on lesions in the

mediastinum, because with this ultrasound probe, they can actually see areas
around the esophagus and trachea.”
EUS and computed tomography
(CT)-guided needle biopsies often take
the place of exploratory surgery, helping
to ensure that, as much as possible, such
invasive procedures are used for treatment rather than for diagnosis.
The whole diagnostic process usually
takes about five to seven working days.
If a cancer is found, Dr. Weiser refers
the patient to the proper oncology
department. She might also arrange
consultations with other specialists,
ranging from endocrinologists to
ophthalmologists to psychiatrists.
When it is not cancer
In the first 263 patients evaluated
in the Cancer Diagnosis Clinic, 166
cases of cancer were diagnosed: 29%
were pancreatic cancer, 14% were other
gastrointestinal malignancies (colon,
gall bladder, duodenal, esophageal,
and rectal cancers), and 14% were
lymphoma. Thirty-seven percent of
patients ended up not having cancer
at all.

Among the conditions that can
mimic cancer are autoimmune disorders,
chronic fatigue syndrome, nonspecific
adenopathy, fibrous dysplasia, Paget’s
disease, and nonmalignant cysts or
hemangiomas. Also, sarcoidosis can
cause adenopathy that looks like
lymphoma on radiographs, Dr. Weiser
said, and other unusual infectious
processes can masquerade as cancer.
So, what does a cancer center do
with these patients?
“For the most part, we send them
back home,” Dr. Weiser said.
The exception to that rule would
be a patient with a mass in a location
that made a biopsy unusually difficult or
dangerous. If the mass was not obviously
malignant, such a patient would be
followed up radiologically.
Whether a patient goes home with
a diagnosis of “no cancer” in the mass
for which they were referred or leaves
the clinic to begin cancer treatments,
the waiting is over. But the Cancer
Diagnosis Clinic does more than relieve
patient anxiety.
“I think it has served the institution,
because we have brought in patients
who might not have been seen here,”
Dr. Escalante said. “It has served the
physician community, because we have
been able to help them treat patients,
many with not-as-common cancers.
And the patients likely benefit from
oncologists and radiation therapists
and other cancer care providers we
have here, and they can go onto
protocols or other specialty-type
treatments that may not be offered
in the community.” ●
To refer a patient to the Cancer Diagnosis
Clinic, physicians should call the New
Patient Referral Office between 8 a.m.
and 5 p.m. Central time, Monday
through Friday. The telephone number
is (800) 392-1611, or (713) 792-6161
in the Houston area or outside the
United States. The fax number is
(713) 792-2504.
FOR MORE INFORMATION, contact
Dr. Weiser at (713) 792-2352.
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The Center for Research on Minority Health:
Working with the Community to End Health
by Stephanie Deming

“I

’m tired of reports,”
said Lovell Jones, Ph.D.,
referring to the flood of
articles confirming that minority populations in the United
States suffer from a disproportionate burden of certain cancers. For more than a decade,
Dr. Jones, who directs the
Center for Research on Minority Health at The University
of Texas M. D. Anderson
Cancer Center, has been
challenging the health-care
community to move beyond
tabulating disparities to investigating their underlying causes.
Barriers to access are a major and
well-documented source of health
disparities, and Dr. Jones argues
passionately about the need for social
changes—such as an end to subtle racial
discrimination in the health-care system
and the removal of financial barriers—
to make health care equally accessible
to all members of society. However, he
said, “Access is part of the problem, but
I don’t think it’s the whole problem.”
Other factors that Center investigators
are studying for their potential role in
health disparities include environmental, cultural, and biological influences.
Collaboration with the minority
communities that it studies is a core
value of the Center for Research on
Minority Health, which is currently part
of M. D. Anderson’s Office of Institutional Diversity. “It’s a two-way street,”
said Dr. Jones. The Center has worked
hard to develop and maintain strong
relationships with minority communities throughout the Houston area,
through the efforts of outreach representatives to the African-American, AsianAmerican, and Hispanic communities.
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Through these outreach programs,
Dr. Jones explained, “you begin to
build relationships in the community
and involve them in not only the
implementation of the study but also
the study design.” And, he pointed out,
the relationships benefit both the
community and the Center. “One of
the things that [traditionally] happens
with research grants,” said Dr. Jones,
“is that you receive a grant, you build
up a network, and then when the grant
goes away, the network goes away. The
Center is a stable force that maintains
those connections and contacts with
the various populations we work with.”
Asian-American Health
Needs Assessment
“We have here in Houston one of
the largest and fastest-growing AsianAmerican communities in the nation,”
noted Beverly Gor, Ed.D., associate
director of community relations and
Asian-American outreach representative
for the Center, “but no one has ever
looked at health needs [in this community] on a comprehensive basis.” To
address this problem, Dr. Gor is heading
up the Asian-American Health Needs
Assessment, a project designed to gather
comprehensive data on health-related
behaviors and attitudes among Asian
Americans living in Harris, Brazoria, Fort
Bend, and Galveston counties in Texas.
After they conceived the idea for this
study, Dr. Gor and her colleagues from
the Center met with the Texas Department of Health, which conducts an
annual random-digit-dialing telephone
survey of Texas residents called the
Behavioral Risk Factors Surveillance
System (BRFSS) survey. The Texas
Department of Health enthusiastically
supported the Center’s proposed project
and helped Center staff adapt the BRFSS
survey for their specialized study. Dr. Gor
and her colleagues added questions about
cancer knowledge and cancer screening
behaviors, environmental exposures
(evidence suggests that some environmental exposures might be related to
cancer rates), and degree of accultura-

Danielle Baham, M.S., and Dr. Lovell Jones
Houston area by zip code. Baham and Dr. Jones, wh
at M. D. Anderson, are studying the effects of diet a
African-American women.
tion. They also had the questionnaire
translated into Chinese and Vietnamese
to allow non-English–speaking households to participate.
To determine whether the survey
questions were culturally sensitive and
would be interpreted by the target
population as the researchers intended,
Center staff presented the modified
questionnaire to a focus group of
Chinese Americans and Vietnamese
Americans. The feedback was sometimes surprising. “We had a lot of
discussion on the mental health question,” said Dr. Gor. “We found out that
in Vietnamese, when you translate that
question literally, it’s ‘are you sane or
are you crazy?’ So that was a real eyeopener.” The focus group participants
also pointed out potential problems
with questions about alcohol abuse
and with having male interviewers
ask women about mammography
and breast self-examination.
Preliminary field-testing of the
questionnaires is complete, and re-

Disparities

Collaboration between M. D. Anderson,
University of Puerto Rico to Address
Cancer in Minority Populations
by Heather Russell

T

s study a map showing the demographics of the
ho directs the Center for Research on Minority Health
nd exercise on breast cancer risk in premenopausal
searchers hope to complete telephone
interviews with 400 Chinese-American
and 400 Vietnamese-American households by the spring of 2003. The data
gathered through the surveys will be
analyzed and shared with the AsianAmerican community and with the
Texas Department of Health and other
health-care organizations. The results
should reveal what types of health
education programs are needed and
suggest areas for further research.
Having the baseline data should also,
according to Dr. Gor, make it easier
for community groups to gain funding
for health-related research.
A NU LIFE
Studies consistently show that
the incidence of premenopausal breast
cancer is significantly higher in AfricanAmerican women than in white women.
Researchers in the Center for Research
on Minority Health, led by Drs. Jones
and Gor along with Danielle Baham,
M.S., have designed a trial to investi-

he University of Texas M. D.
Anderson Cancer Center and
The University of Puerto Rico
Cancer Center are joining forces in
a collaborative research program to
study cancer in Hispanic populations.
A five-year, $15 million grant
awarded by the National Cancer
Institute and the Minority Institution
Cancer Center Partnership will fund
research as well as diversity training,
physician education, and community
outreach. The first research projects
will address the molecular epidemiology of head and neck cancer, breast
cancer, and acute promyelocytic
leukemia.
“These activities will enhance our
cancer research capability and address
the burden of cancer in minority
populations, particularly Hispanics,”
said Gabriel Lopez-Berestein, M.D.,
principal investigator and professor of
bioimmunotherapy at M. D. Anderson.
“Findings from this research may enable
us to develop ethnic-specific cancer
prevention strategies in addition to
allowing minority fellows and graduate
students from both institutions the
opportunity to be involved in multidisciplinary research.”
Researchers from M. D. Anderson
and Puerto Rico will travel to each
center to present ideas for potential
projects. Colleagues with similar

gate whether premenopausal AfricanAmerican women can lower their risk
of breast cancer through modifications
in diet and exercise. Specifically, the
investigators wish to examine whether
a low-fat, high-fiber diet along with
exercise will reduce estradiol levels
and whether estradiol levels will
correlate with putative molecular and
genetic markers of increased breast
cancer risk. These markers include
circulating triglycerides and free fatty
acids, oxidative DNA damage, and
serum lipid peroxidation. During the
trial, researchers will monitor adherence

interests will then team up to address
a particular disparity. Researchers
will communicate through regular
videoconferences to offer updates,
implement new strategies, and stimulate additional project ideas. One of
the goals of this comprehensive crosstraining program is to increase the
number of Hispanic students interested in research careers.
“By learning from physicians
already treating patients in Hispanic
populations, we will increase our own
sensitivity to minority needs,” said
Harry R. Gibbs, M.D., vice president
of institutional diversity at M. D.
Anderson. “It is our hope that this
collaboration will not only improve
our level of patient care but also be
the beginning of many long-term
partnerships with cancer centers
across the nation and the world.”
Developing partnerships with
institutions who work with underserved patients is just one of the
many goals outlined by the Office
of Institutional Diversity at M. D.
Anderson. The office also is dedicated
to increasing the recruitment of
minority and female applicants,
working with high schools and
colleges to encourage women and
minorities to pursue science careers,
and offering mentoring, employee
forums, and other activities designed
to promote the advantages of a
diverse workforce. ●

to the study diet by periodically asking
participants to describe their food
intake during the previous 24 hours
and by performing anthropometric
measurements.
A NU LIFE is funded by the American Cancer Society. The first participants will be enrolled in early 2003, and
the target enrollment is 200 AfricanAmerican women. To be eligible,
women must be premenopausal, be
between 25 and 45 years of age, and have
no personal history of cancer, diabetes,
or heart disease. Participants in the trial
(Continued on page 6)
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